Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

two arrows pointing different directions
Biotech

TCGX picks migraine biotech TriGemX to take public via SPAC

Life sciences-focused investment firm TCGX will use a special purpose acquisition company to take migraine-minded TriGemX Bio public.
James Waldron Oct 19, 2026 11:05am
x

Fierce Biotech Layoff Tracker 2026: EyePoint halves headcount

Oct 19, 2026 11:00am
From Scientific Hypothesis to Clinical Practice The Next Chapter for CLDN182

The next chapter of CLDN18.2-directed innovation

Brought to you by Astellas Pharma US
Eli Lilly booth at AACR 2026

Lilly allies with Metis in $1.1B AI nanoparticle discovery deal

Oct 19, 2026 10:45am
Aligning drug discovery around patient benefit from the outset Connecting human insights to better decisions

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions

Brought to you by IQVIA Laboratories
Gilead

Gilead is ‘sitting on a foundational asset’ with oral UC drug

Oct 19, 2026 9:46am